Background. In a prospective randomized study, we compared topical 4% amethocaine gel (Ametop TM ) with 2% lidocaine in®ltration for analgesia for radial artery cannulation. A previous study had shown topical analgesia with EMLA cream reduced pain, shortened cannulation time, and improved success rates when compared with lidocaine in®ltration.
Radial artery cannulation is a painful procedure, and standard analgesia is subcutaneous in®ltration with lidocaine before cannulation. Topical analgesia with EMLA cream has been shown to shorten cannulation time, improve the success rate, and reduce the pain of radial artery cannulation.
1 Despite these ®ndings, EMLA cream is not widely used for this procedure, and this may be because of the slow onset of action of EMLA (2 h). Compared with EMLA, 4% amethocaine provides a faster onset and longer duration of analgesia for venous cannulation. 2 We postulated that the vasodilatory properties of amethocaine might further improve the speed and success rate of radial artery cannulation by arterial dilatation and prevention of re¯ex vasoconstriction. In this study, we evaluated the use of topical 4% amethocaine gel for arterial cannulation by comparing it with lidocaine in®ltration.
Methods and results
We recruited 100 adult patients undergoing elective cardiac surgery. The study received ethical approval and informed consent was obtained from all patients. Patients with an abnormal Allen's test or known sensitivity to local anaesthetics were excluded from the study. Patients were randomized to receive either topical 4% amethocaine gel (AmetopÔ) or 2% lidocaine in®ltration. Amethocaine gel was applied to both wrists under an occlusive dressing over the proposed puncture site at least 1 h before attempted arterial cannulation. Alternatively, 2% lidocaine (0.5±0.7 ml) was in®ltrated with a 25-gauge needle at least 1 min before attempted arterial cannulation. All patients received premedication with lorazepam 1±3 mg, 2 h before transfer to the anaesthetic room.
Before arterial cannulation, the wrist was hyperextended over a gauze roll. The occlusive dressing and excess amethocaine gel were removed, or 2% lidocaine in®ltrated, according to randomization. An experienced registrar or consultant anaesthetist attempted cannulation with a 20-gauge AbbocathÔ cannula (Baxter).
Immediately after the procedure, each patient was asked to complete a 10 cm visual analogue scale (VAS): 0=no pain, 10=worst pain imaginable; and a verbal pain score (VPS): 0=no pain, 1=mild, 2=moderate, 3=severe pain. These pain scales were discussed with the patient at the preoperative visit.
We measured the time to successful cannulation. The clock started as the cannula touched the skin to start cannulation and stopped as soon as the arterial line was connected. Failure to cannulate within 10 min or procedures abandoned earlier were classed as failures. Additional lidocaine was in®ltrated in patients who complained of pain or looked uncomfortable.
This requirement for additional lidocaine was noted, in addition to any erythema of the amethocaine gel site.
One-tailed power analysis suggested that the study had 80% power to detect a difference in cannulation time of 45 s between the groups (SD 90 s). Power analysis was one tailed, as we were primarily interested in a result in favour of amethocaine. The SD of 90 s used in power analysis was an estimate based on a small pilot study assuming normal distribution. However, the study data were not normally distributed and further statistical analysis used Mann± Whitney U and chi-squared tests. The statistical analysis was performed with SPSS v. 9.0 on a Windows based PC.
Of 100 patients enrolled, one was too sedated to give a pain score and his data were excluded; this left 99 sets of data for analysis. Both groups were similar in terms of age, sex, height, weight, and operative procedure (P=0.55±0.85). Median time to cannulation was 65 s for the amethocaine group, IQR 41±142, and 59 s for lidocaine, IQR 40±105 (95% con®dence intervals for difference ±13.99 and 29.02, respectively). Four-point pain scoring by the patient showed a median of 2 in both groups (IQR 1±3.5 for lidocaine and 0±4 for amethocaine, P=0.93, 95% con®dence intervals were ±1.0 to 1.0).
The median, IQR, and range of VAS for pain are shown in Figure 1 . Failure to cannulate occurred in ®ve of the amethocaine group and seven of the lidocaine group (P=0.54); this failed cannulation rate of 12% correlates well with rates reported previously.
3 4 Additional lidocaine was required in seven of the lidocaine group and 11 of the amethocaine group (P=0.54). There was no correlation between the failure to cannulate and additional lidocaine. There were no serious skin reactions to the amethocaine application. Erythema of the proposed cannulation site was common.
Comment
A number of studies have shown EMLA to be superior to lidocaine in®ltration in providing analgesia for radial artery cannulation.
1 5±7 A study by Joly and colleagues compared EMLA and lidocaine in®ltration in over 500 patients and found superior analgesia, a higher success rate and shorter cannulation times in the EMLA group.
1 Against this background, our results appear surprising until the studies are compared more closely. We cannulated the radial artery with a 20-gauge cannula whereas the study by Joly and colleagues used an 18-gauge cannula and a 5f sheath. The latter allocated unpremedicated patients according to day of surgery: that is all patients on 1 day received topical in®ltration and those on the next day, EMLA. Patients in our study were premedicated. Although premedication with a benzodiazepine does not provide analgesia, it is well recognized that a premedicated patient may perceive and recall pain differently. The populations were slightly different, in that Joly's patients were attending for coronary angiography, and ours for cardiac surgery. These two groups may perceive the importance of good analgesia for arterial cannulation differently.
It is also worth noting that our sample size is smaller than Joly's study. Based on our power analysis, 100 patients were required to detect a mean difference in time to successful arterial cannulation of 45 s. We feel that this is the minimum mean difference required to justify the greater effort and expense in the use of amethocaine gel in clinical practice. Presently, one tube of AmetopÔ gel costs £1.15 and a 5 ml ampoule of 2% lidocaine costs 23 pence.
We have shown that in premedicated patients, topical 4% amethocaine gel and lidocaine in®ltration are equally effective in providing analgesia for radial artery cannulation. Success rate and speed of cannulation were also similar for both methods. As amethocaine gel is both more expensive and time consuming to apply, we cannot recommend its routine use for arterial cannulation instead of lidocaine in®ltration. Lidocaine or amethocaine for radial artery cannulation?
Sore throat is a common complication after surgery. It affects patient satisfaction and can affect the patient's activities after leaving hospital.
1±3
Several factors contribute to postoperative sore throat. Reporting of a sore throat can be affected by whether this symptom is asked about directly or indirectly. 4 The incidence varies with the method of airway management. Tracheal intubation (ETT) is associated with a greater incidence of sore throat than laryngeal mask airway (LMA ² ) or facemask (FM). 2 Studies of postoperative sore throat have not distinguished ambulatory surgical patients from inpatients. We set out to determine which patient characteristics and operative factors predict sore throat in ambulatory surgical patients.
Methods and results
We enrolled 17 638 consecutive ambulatory surgical patients in a prospective observational study over 3 yr with ASA physical status I, II, and III, aged 12 yr and older. The hospital's ethics committee approved the study.
We recorded the patients' age, sex, weight, height, and ASA physical status on a standardized information sheet. The type and duration of surgery, operative airway management (ETT, LMA, or FM) tracheal tube size, patient position during surgery, drugs given, and duration of stay in ² LMA â is the property of Intavent Limited.
